D. Welch

D. Welch, S. P. Tomasovic, E. Armour, 1987, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA

D. Welch, D. Hurst, Q. Sang, 2011, Journal of Cancer.

Metastasis-suppressor genes: a review and perspective on an emerging field.

C. Rinker-Schaeffer, D. Welch, M. Sokoloff, 2000, Journal of the National Cancer Institute.

Development and characterization of a rat model for locally recurring mammary tumors: sensitivities to 5-fluoro-2'-deoxyuridine, adriamycin, and X-irradiation.

D. Welch, P. Aeed, J. Estrada, 1988, Cancer research.

Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.

H. Kleinman, D. Welch, J. Vostal, 2005, Cancer research.

Basement membrane degradative enzymes as possible markers of tumor metastasis.

T. Irimura, G. Nicolson, M. Nakajima, 1986, Progress in clinical and biological research.

The KISS1 metastasis suppressor: a good night kiss for disseminated cancer cells.

D. Welch, B. Beck, Benjamin Beck, 2010, European journal of cancer.

BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.

Kedar S Vaidya, D. Welch, D. Hurst, 2008, The American journal of pathology.

Experimental model for locally recurring mammary tumors. Development, morphology, karyotype, growth kinetics, and experimental metastatic potential

D. Welch, P. Aeed, J. Estrada, 1989, Cancer.

Cancer metastasis : biologic basis and therapeutics

D. Lyden, D. Welch, B. Psaila, 2011 .

Partial pneumonectomy enhances melanoma metastasis to mouse lungs.

D. Welch, S. Rannels, D. Rannels, 2002, Chest.

Loss of Breast Cancer Metastasis Suppressor 1 Protein Expression Predicts Reduced Disease-Free Survival in Subsets of Breast Cancer Patients

T. Choueiri, G. Casey, N. Nowak, 2006, Clinical Cancer Research.

Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1.

A. Alessandrini, D. Welch, D. Mauger, 2002, Experimental cell research.

Roles of mitochondrial genetics in cancer metastasis.

I. Rigoutsos, D. Welch, Christian Foster, 2022, Trends in cancer.

Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer

D. Welch, R. Samant, Brandon J. Metge, 2008, Clinical & Experimental Metastasis.

Generation of Mitochondrial-nuclear eXchange Mice via Pronuclear Transfer.

S. Ballinger, R. Kesterson, D. Welch, 2016, Bio-protocol.

Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer

Mihaela E. Sardiu, D. Koestler, D. Welch, 2022, BMC cancer.

Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma.

T. Tsuruo, G. Nicolson, M. Nakajima, 1993, Cancer research.

Role of BRMS1 in Breast Carcinoma Metastasis

D. Welch, R. Samant, Lalita R. Shevde, 2002 .

The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762nf mammary adenocarcinoma cells

M. Nakajima, D. Welch, P. Aeed, 1988, International journal of cancer.

Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells

D. Welch, L. Demers, A. Manni, 2004, Clinical & Experimental Metastasis.

Inhibition of tumor cell invasion by verapamil.

R. J. Geary, M. Hendrix, D. Welch, 1991, Pigment cell research.

The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines

D. Theodorescu, Michael A. Harding, D. Welch, 2004, Clinical & Experimental Metastasis.

Correlation between reduction of metastasis in the MDA‐MB‐435 model system and increased expression of the Kai‐1 protein

J. Barrett, B. Weissman, A. White, 1998, Molecular carcinogenesis.

NGF reprograms metastatic melanoma to a bipotent glial-melanocyte neural crest-like precursor

P. Kulesa, C. Bailey, D. Welch, 2017, Biology Open.

BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-κB binding site of the uPA promoter

G. Casey, S. Sizemore, M. Cicek, 2009, Clinical & Experimental Metastasis.

Breast Cancer Metastasis Suppressor 1 Inhibits Gene Expression by Targeting Nuclear Factor-KB Activity

G. Casey, N. Sizemore, D. Welch, 2005 .

CellsPrimary Breast Tumors and Corresponding Circulating Tumor Breast Cancer Metastasis Suppressor-1 Promoter Methylation in

G. Kallergi, V. Georgoulias, D. Welch, 2013 .

Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival

V. A. Flørenes, R. Holm, A. Slipicevic, 2012, BMC Cancer.

Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells.

Joseph C. Shope, J. Shope, D. Welch, 2005, Cancer research.

Breast cancer metastasis suppressor 1: Update

D. Welch, W. Meehan, 2004, Clinical & Experimental Metastasis.

Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-κB activation

G. Casey, A. Chambers, D. Welch, 2007, Molecular Cancer.

What defines a useful marker of metastasis in human cancer?

C. Rinker-Schaeffer, D. Welch, 1999, Journal of the National Cancer Institute.

Targeting the untargetable? Nodal expression in TNBC

D. Welch, E. Young, Danny R. Welch, 2016, Cell cycle.

Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to Adriamycin, 5-fluoro-2′-deoxyuridine and methotrexate treatment in vitro

G. Nicolson, D. Welch, 1983, Clinical & Experimental Metastasis.

Heat stress proteins and experimental cancer metastasis.

D. Welch, S. P. Tomasovic, 1986, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Heterogeneous response and clonal drift of sensitivities of metastatic 13762NF mammary adenocarcinoma clones to gamma-radiation in vitro.

G. Nicolson, L. Milas, D. Welch, 1983, Cancer research.

MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4

N. Agarwal, T. Iwakuma, D. Welch, 2012, Oncogene.

Preferential organ attachment and invasion in vitro by B16 melanoma cells selected for differing metastatic colonization and invasive properties.

G. Nicolson, C. Basson, D. Welch, 1985, Invasion and Metastasis.

Effects of α-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice

D. Welch, L. Demers, A. Manni, 2004, Clinical and Experimental Metastasis.

Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells.

J. Bonventre, A. Alessandrini, R. Erikson, 2000, Cancer Research.

Advances in Brief Transfection of Constitutively Active Mitogen-activated Protein / Extracellular Signal-regulated Kinase Kinase Confers Tumorigenic and Metastatic Potentials to NIH 3 T 3 Cells 1

J. Bonventre, A. Alessandrini, R. Erikson, 2000 .

Maintaining GFP tissue fluorescence through bone decalcification and long-term storage.

N. Christensen, D. Welch, L. Budgeon, 2002, BioTechniques.

Preclinical Evaluation of Gilteritinib on NPM1-ALK–Driven Anaplastic Large Cell Lymphoma Cells

R. Jensen, S. Kuravi, D. Welch, 2021, Molecular Cancer Research.

KISS1 metastasis suppression and emergent pathways

D. Welch, M. Miele, J. Harms, 2004, Clinical & Experimental Metastasis.

Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression

B. Weimer, D. Welch, D. Dewald, 2007, Clinical & Experimental Metastasis.

Heterogeneous Response and Clonal Drift of Sensitivities of Metastatic 13762NF Mammary Adenocarcinoma Clones to y-Radiation in Wfro1

G. Nicolson, L. Milas, D. Welch, 2006 .

Analysis of mechanisms underlying BRMS1 suppression of metastasis

N. Christensen, T. Sakamaki, D. Welch, 2004, Clinical & Experimental Metastasis.

Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas

W. Grizzle, D. Welch, B. Karanam, 2014, Clinical & Experimental Metastasis.

Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).

D. Welch, D. Hurst, M. T. Debies, 2006, Cancer letters.

Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23)

P. Steeg, D. Welch, M. Miele, 1997, Clinical & Experimental Metastasis.

Defining the Hallmarks of Metastasis.

D. Welch, D. Hurst, Danny R Welch, 2019, Cancer research.

The second genome: Effects of the mitochondrial genome on cancer progression.

D. Welch, T. Beadnell, Adam D. Scheid, 2019, Advances in cancer research.

Technical considerations for studying cancer metastasis in vivo

D. Welch, 1997, Clinical & Experimental Metastasis.

Molecular biology of breast cancer metastasis: Genetic regulation of human breast carcinoma metastasis

P. Steeg, C. Rinker-Schaeffer, D. Welch, 2000, Breast Cancer Research.

Mucosally-derived HPV-40 can infect both human genital foreskin and cutaneous hand skin tissues grafted into athymic mice.

N. Christensen, D. Welch, N. Cladel, 2003, Virus research.

Suppression of C8161 melanoma metastatic ability by chromosome 6 induces differentiation-associated tyrosinase and decreases proliferation on adhesion-restrictive substrates mediated by overexpression of p21WAF1 and down-regulation of bcl-2 and cyclin D3.

D. Welch, M. Rieber, M. Strasberg Rieber, 2001, Biochemical and biophysical research communications.

Cancer Metastasis — Related Genes

D. Welch, 2002, Cancer Metastasis — Biology and Treatment.

The Role of KISS1 in Melanoma Metastasis Suppression

D. Welch, J. Harms, 2002 .

Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alpha.

N. Dean, D. Welch, C. Bennett, 1998, Cancer letters.

Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies.

G. Nicolson, D. Welch, T. Lembo, 1988, Cancer research.

MCF-7 Cells Expressing Nuclear Associated Lysyl Oxidase-like 2 (LOXL2) Exhibit an Epithelial-to-Mesenchymal Transition (EMT) Phenotype and Are Highly Invasive in Vitro*

D. Welch, D. Moore, Li Xu, 2013, The Journal of Biological Chemistry.

The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.

Z. Su, H. Jiang, P. Fisher, 1995, Oncogene.

Molecular mechanisms controlling human melanoma progression and metastasis.

D. Welch, S. F. Goldberg, 1997, Pathobiology : journal of immunopathology, molecular and cellular biology.

Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate

D. Welch, J. Harms, S. F. Goldberg, 2004, Clinical & Experimental Metastasis.

A human melanoma metastasis‐suppressor locus maps to 6q16.3‐q23

C. Morelli, B. Weissman, D. Welch, 2000, International journal of cancer.

Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1).

B. Weissman, P. Vojta, D. Welch, 1998, Genomics.

Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1.

J. H. Lee, D. Welch, Ji Hyun Lee, 1997, Cancer research.

KiSS-1, a novel human malignant melanoma metastasis-suppressor gene.

J M Trent, J. Trent, J. Trent, 1996, Journal of the National Cancer Institute.

Suppression of human melanoma metastasis by introduction of chromosome 6 may be partially due to inhibition of motility, but not to inhibition of invasion.

D. Welch, M. Miele, J. You, 1995, Biochemical and biophysical research communications.

Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line

E. Seftor, M. Hendrix, E. Seftor, 1991, International journal of cancer.

Implications of tumor progression on clinical oncology

D. Welch, S. P. Tomasovic, Danny R. Welch, 1985, Clinical & Experimental Metastasis.

Factors Involved in the Development and Maintenance of Tumor Heterogeneity

D. Welch, 1989 .

Metastasis suppressor genes at the interface between the environment and tumor cell growth.

D. Welch, D. Hurst, 2011, International review of cell and molecular biology.

Human melanoma cell invasion is inhibited in vitro by swainsonine and deoxymannojirimycin with a concomitant decrease in collagenase IV expression

L. Liotta, M. Hendrix, W. Stetler-Stevenson, 1991, Melanoma research.

Chromosome and DNA analyses of rat 13762NF mammary adenocarcinoma cell lines and clones of different metastatic potentials

G. Nicolson, S. Pathak, D. Welch, 1984, Clinical & Experimental Metastasis.

Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma.

G. Nicolson, D. Welch, T. Kawaguchi, 1982, Journal of the National Cancer Institute.

Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells

C. Pethiyagoda, T. Fleming, D. Welch, 2004, Clinical & Experimental Metastasis.

Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell’s Journey

D. Welch, A. Brinker, C. J. Vivian, 2014, Cancer Microenvironment.

Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.

G. Nicolson, M. Nakajima, D. Welch, 1987, Cancer research.

Multiple phenotypic divergence of mammary adenocarcinoma cell clones.

G. Nicolson, L. Milas, D. Welch, 1984, Clinical & Experimental Metastasis.

Mechanisms of breast cancer metastasis

Kevin J. Cheung, L. Yates, M. Detmar, 2021, Clinical & experimental metastasis.

Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5

M. Hollingsworth, T. Iwakuma, M. O’Neil, 2020, British journal of cancer.

Multiple phenotypic divergence of mammary adenocarcinoma cell clones

G. Nicolson, D. Krizman, D. Welch, 1984, Clinical & Experimental Metastasis.

The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 in and Promotes Tumorigenesis in Mice.

T. Iwakuma, O. Tawfik, R. Jensen, 2019, Gastroenterology.

Metastasis: recent discoveries and novel treatment strategies

S. Eccles, D. Welch, Suzanne A Eccles, 2007, The Lancet.

Roles of the mitochondrial genetics in cancer metastasis: not to be ignored any longer

D. Welch, C. J. Vivian, T. Beadnell, 2018, Cancer and Metastasis Reviews.

Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1.

K. Broman, K. Hunter, D. Welch, 2001, Cancer research.

Breast cancer metastasis suppressor 1 coordinately regulates metastasis‐associated microRNA expression

Dongquan Chen, Kedar S Vaidya, D. Welch, 2009, International journal of cancer.

Metastamir: the field of metastasis-regulatory microRNA is spreading.

D. Welch, D. Hurst, Mick D. Edmonds, 2009, Cancer research.

Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration

B. Sarcevic, O. Bernard, D. Welch, 2016, Cell cycle.

Mitochondrial Genomic Backgrounds Affect Nuclear DNA Methylation and Gene Expression.

G. Gooden, D. Koestler, B. Salhia, 2017, Cancer research.

Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP.

L. Freedman, D. Welch, M. Takata, 2003, Cancer research.

In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.

W. Cavenee, F. Furnari, H. Huang, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Metastasis of hormone receptor positive breast cancer.

D. Welch, M. M. Richert, 2009, Cancer treatment and research.

MOLECULAR MECHANISMS OF BREAST CANCER METASTASIS: GAP JUNCTION INTERCELLULAR COMMUNICATION AND THE BONE MICROENVIRONMENT

R. Sanderson, D. Welch, A. Mastro, 2010 .

Metastasis Suppressors and the Tumor Microenvironment

D. Welch, Thomas M. Bodenstine, 2008, Cancer Microenvironment.

Osteopontin Knockdown Suppresses Tumorigenicity of Human Metastatic Breast Carcinoma, MDA-MB-435

G. Casey, A. Chambers, D. Welch, 2006, Clinical & Experimental Metastasis.

Breast Cancer Metastasis Suppressor-1 Promoter Methylation in Primary Breast Tumors and Corresponding Circulating Tumor Cells

Vassilis Georgoulias, G. Kallergi, V. Georgoulias, 2013, Molecular Cancer Research.

Metastasis suppressor pathways--an evolving paradigm.

D. Welch, L. Shevde, Danny R Welch, 2003, Cancer letters.

Metastasis Genes in Breast Cancer Metastasis to Bone

D. Welch, 2003 .

Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload.

S. Ballinger, R. Kesterson, L. Dell’Italia, 2013, The Biochemical journal.

Breast cancer metastatic potential: Correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells

D. Welch, H. Donahue, R. Samant, 2004, International journal of cancer.

Metastasis suppressors and the tumor microenvironment.

Leah M. Cook, D. Welch, D. Hurst, 2011, Seminars in cancer biology.

The KISS1 metastasis suppressor: mechanistic insights and clinical utility.

D. Welch, K. Nash, 2006, Frontiers in bioscience : a journal and virtual library.

Imaging of epidermal growth factor receptor on single breast cancer cells using surface-enhanced Raman spectroscopy.

Lifu Xiao, D. Welch, Anhong Zhou, 2014, Analytica chimica acta.

Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease.

G. Page, B. V. Van Tine, S. Mukherjee, 2007, The American journal of pathology.

Mitochondrial Genetics Regulate Breast Cancer Tumorigenicity and Metastatic Potential.

S. Ballinger, R. Kesterson, D. Welch, 2015, Cancer research.

Genetic background is an important determinant of metastatic potential

E. Liu, K. Hunter, D. Welch, 2003, Nature Genetics.

Comparative sequence analysis in eight inbred strains of the metastasis modifier QTL candidate gene Brms1

Howard H. Yang, K. Hunter, D. Welch, 2002, Mammalian Genome.

Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma

P. Meltzer, J. Trent, E. Kleinerman, 2014, Clinical Cancer Research.

Beyond the Primary Tumor: Progression, Invasion, and Metastasis

D. Welch, D. Hurst, 2017 .

Invasion and Metastasis

L. Matrisian, D. Welch, 2008 .

Do we need to redefine a cancer metastasis and staging definitions?

D. Welch, 2006, Breast disease.

Identification and characterization of the murine ortholog (brms1) of breast‐cancer metastasis suppressor 1 (BRMS1)

D. Welch, M. T. Debies, R. Samant, 2002, International journal of cancer.

Breast Cancer Metastasis Suppressor-1 Differentially Modulates Growth Factor Signaling*

Kedar S Vaidya, G. Casey, D. Welch, 2008, Journal of Biological Chemistry.

Angiotropism of Human Melanoma: Studies Involving In Transit and Other Cutaneous Metastases and the Chicken Chorioallantoic Membrane: Implications for Extravascular Melanoma Invasion and Metastasis

H. Kleinman, K. Busam, D. Welch, 2006, The American Journal of dermatopathology.

C16 laminin peptide increases angiotropic extravascular migration of human melanoma cells in a shell‐less chick chorioallantoic membrane assay

H. Kleinman, D. Welch, C. Lugassy, 2007, The British journal of dermatology.

Roles of mitochondria in the hallmarks of metastasis

D. Welch, T. Beadnell, Adam D. Scheid, 2020, British journal of cancer.

Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1

G. Casey, I. Macdonald, A. Chambers, 2008, International journal of cancer.

Metastasis Suppressors and Their Roles in Breast Carcinoma

Kedar S Vaidya, D. Welch, 2007, Journal of Mammary Gland Biology and Neoplasia.

Unraveling the 'TGF-β paradox' one metastamir at a time

D. Welch, D. Hurst, 2013, Breast Cancer Research.

Unraveling the enigmatic complexities of BRMS1‐mediated metastasis suppression

D. Welch, D. Hurst, 2011, FEBS letters.

Alterations of BRMS1-ARID4A Interaction Modify Gene Expression but Still Suppress Metastasis in Human Breast Cancer Cells*

Kedar S Vaidya, M. Accavitti-Loper, D. Welch, 2008, Journal of Biological Chemistry.

Breast Cancer Progression: Controversies and Consensus in the Molecular Mechanisms of Metastasis and EMT

D. Welch, P. Cowin, 2007, Journal of Mammary Gland Biology and Neoplasia.

Highly metastatic 13762NF rat mammary adenocarcinoma cell clones stimulate bone marrow by secretion of granulocyte-macrophage colony-stimulating factor/interleukin-3 activity.

D. Welch, C. McGary, M. Miele, 1995, The American journal of pathology.

KISS1 in breast cancer progression and autophagy

D. Welch, I. Ulasov, A. Borovjagin, 2019, Cancer and Metastasis Reviews.

Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture

G. Page, Martin R. Johnson, D. Welch, 2004, Breast Cancer Research.

Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides.

D. Welch, C. Bennett, B. Miller, 1994, Experimental cell research.

New insights into the role of CXCR4 in prostate cancer metastasis

D. Welch, C. Gladson, 2008, Cancer biology & therapy.

Tumor Cell Invasion-Not All Barriers Are Created Equal.

D. Welch, 2016, Cancer research.

Use of the membrane invasion culture system (mics) as a screen for anti‐invasive agents

M. Hendrix, E. Seftor, D. Welch, 1989, International journal of cancer.

Mitochondrial haplotype of the host stromal microenvironment alters metastasis in a non-cell autonomous manner.

D. Koestler, D. Welch, A. Brinker, 2019, Cancer research.

Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy.

D. Welch, A. Landar, Michelle S. Johnson, 2010, The Biochemical journal.

Metastasis Suppressor Genes: A Brief Review of an Expanding Field

D. Welch, M. M. Richert, Monica M. Richert, 2005 .

Genetic Basis of Human Breast Cancer Metastasis

D. Welch, M. T. Debies, Michael T. Debies, 2001, Journal of Mammary Gland Biology and Neoplasia.

Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice.

D. Welch, L. Demers, A. Manni, 2003, Clinical & experimental metastasis.

Breast Cancer Metastasis Suppressor 1 Inhibits Gene Expression by Targeting Nuclear Factor-κB Activity

G. Casey, D. Welch, R. Fukuyama, 2005 .

Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.

G. Casey, N. Sizemore, D. Welch, 2005, Cancer research.

Perturbation of BRMS1 interactome reveals pathways that impact metastasis

Mihaela E. Sardiu, Md. Sayem Miah, M. Washburn, 2021, PloS one.

Perturbation of BRMS1 interactome reveals pathways that impact cell migration

Mihaela E. Sardiu, Md. Sayem Miah, M. Washburn, 2021, bioRxiv.

Pre-osteoblastic MC3T3-E1 cells promote breast cancer growth in bone in a murine xenograft model

D. Welch, A. Mastro, B. Beck, 2011, Chinese journal of cancer.

Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs

Henry J. Donahue, Danny R. Welch, D. Welch, 2008, Clinical & Experimental Metastasis.

MTBP inhibits migration and metastasis of hepatocellular carcinoma

T. Iwakuma, S. Weinman, D. Welch, 2015, Clinical & Experimental Metastasis.

MTBP inhibits migration and metastasis of hepatocellular carcinoma

N. Agarwal, T. Iwakuma, S. Weinman, 2015, Clinical & Experimental Metastasis.

A new member of the growing family of metastasis suppressors identified in prostate cancer.

K. Hunter, D. Welch, 2003, Journal of the National Cancer Institute.

Breast Cancer Metastasis Suppressor 1 (BRMS1): Robust Biological and Pathological Data, But Still Enigmatic Mechanism of Action.

D. Welch, D. Hurst, C. Manton, 2016, Advances in Cancer Research.

Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer

D. Welch, E. Lianidou, I. Balgkouranidou, 2014, British Journal of Cancer.

Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma

S. Kuravi, D. Welch, C. J. Vivian, 2021, ESMO open.

Role of the tumor microenvironment in regulating the anti-metastatic effect of KISS1

D. Welch, Sitaram Harihar, Thuc Ly, 2020, Clinical & Experimental Metastasis.

Automated quantitative image analysis for ex vivo metastasis assays reveals differing lung composition requirements for metastasis suppression by KISS1

D. Welch, E. Young, K. Strom, 2018, Clinical & Experimental Metastasis.

Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy

N. Shah, D. Welch, A. Karseladze, 2017, Autophagy.

The KISS1 metastasis suppressor appears to reverse the Warburg effect by shifting from glycolysis to mitochondrial beta-oxidation

D. Welch, Wen Liu, Sharon J Manley, 2017, Journal of Molecular Medicine.

Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesis.

Kedar S Vaidya, T. Iwakuma, S. Ballinger, 2014, Cancer research.

Metastasis suppressors in breast cancers: mechanistic insights and clinical potential

D. Welch, W. Denning, Rahul Sharma, 2013, Journal of Molecular Medicine.

Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution

R. Shin, D. Welch, D. Hurst, 2009, Clinical & Experimental Metastasis.

Protein Kinase C δ Involvement in Mammary Tumor Cell Metastasis

S. Kiley, D. Welch, S. Jaken, 1999 .

Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis

J. Karanicolas, Shuang-yin Han, D. Dixon, 2020, Communications Biology.

Mitochondrial polymorphisms contribute to aging phenotypes in MNX mouse models

R. Jensen, D. Welch, A. Brinker, 2018, Cancer and Metastasis Reviews.

Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells

G. Casey, D. Welch, M. Kinter, 2004, Clinical & Experimental Metastasis.

Oncogenes and Tumor Suppressors Breast Cancer Metastasis Suppressor-1 Promoter Methylation in Primary Breast Tumors and Corresponding Circulating Tumor Cells

G. Kallergi, V. Georgoulias, D. Welch, 2013 .

Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis

M. Martinka, Gang Li, D. Welch, 2011, Oncogene.

Breast cancer metastasis to bone: evolving models and research challenges.

D. Welch, A. Mastro, H. Donahue, 2003, Journal of musculoskeletal & neuronal interactions.

Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome‐wide shRNA screen

S. Natsugoe, T. Iwakuma, D. Welch, 2016, International journal of cancer.

A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis.

D. Griggs, N. Christensen, D. Welch, 2004, Clinical & experimental metastasis.

Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis

R. Kesterson, R. Desmond, Leah M. Cook, 2012, Clinical & Experimental Metastasis.

A Shift from Nuclear to Cytoplasmic Breast Cancer Metastasis Suppressor 1 Expression Is Associated with Highly Proliferative Estrogen Receptor-Negative Breast Cancers

Martin R. Johnson, R. Seitz, D. Welch, 2009, Tumor Biology.

Metastasis: a current perspective

A. Chambers, D. Welch, D. Denhardt, 2008 .

The skeleton as a unique environment for breast cancer cells

D. Welch, A. Mastro, C. Gay, 2004, Clinical & Experimental Metastasis.

MDA-MB-435 human breast carcinoma metastasis to bone

D. Welch, J. Harms, 2004, Clinical & Experimental Metastasis.

Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication.

D. Welch, H. Donahue, M. Saunders, 2001, Cancer research.

Comparison of tumor cell invasion assays: human amnion versus reconstituted basement membrane barriers.

M. Hendrix, E. Seftor, D. Welch, 1989, Invasion and Metastasis.

Tumor and Stem Cell Biology MetastasisSuppressorKISS 1 Seems toReverse theWarburg Effect by Enhancing Mitochondrial Biogenesis

Kedar S Vaidya, T. Iwakuma, S. Ballinger, 2014 .

Mitochondrial genetics cooperate with nuclear genetics to selectively alter immune cell development/trafficking.

D. Welch, T. Beadnell, M. Markiewicz, 2019, Biochimica et biophysica acta. Molecular basis of disease.

KAI1, a putative marker for metastatic potential in human breast cancer.

B. Weissman, D. Welch, X. Yang, 1997, Cancer letters.

Vital Stain to Study Cell Invasion in Modified Boyden Chamber Assay

N. Christensen, D. Welch, 2003 .

Chloroquine-Inducible Par-4 Secretion Is Essential for Tumor Cell Apoptosis and Inhibition of Metastasis

Qing Jun Wang, J. Maranchie, V. Rangnekar, 2017, Cell reports.

Clinical significance of KISS1 protein expression for brain invasion and metastasis

O. Olopade, D. Welch, B. Thaci, 2012, Cancer.

Essential Components of Cancer Education.

H. Nakshatri, R. Jensen, A. Riegel, 2015, Cancer Research.

Functional characterization of NPM1–TYK2 fusion oncogene

K. Elenitoba-Johnson, I. Saadi, R. Jensen, 2022, npj Precision Oncology.

Mitochondrial Bioenergetics of Metastatic Breast Cancer Cells in Response to Dynamic Changes in Oxygen Tension: Effects of HIF-1α

D. Welch, A. Landar, V. Darley-Usmar, 2013, PloS one.

Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition.

Kedar S Vaidya, Leah M. Cook, D. Welch, 2010, Cancer research.

Linking metastasis suppression with metastamiR regulation

D. Welch, D. Hurst, Mick D. Edmonds, 2009, Cell cycle.

Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model

D. Welch, D. Hurst, Mick D. Edmonds, 2008, Clinical & Experimental Metastasis.

Microarrays bring new insights into understanding of breast cancer metastasis to bone

D. Welch, Danny R Welch, 2003, Breast Cancer Research.

Quantitation of human melanoma, carcinoma and sarcoma tumor cell adhesion to lymphatic endothelium.

M. Hendrix, S. Leong, D. Welch, 1990, Lymphology.

Augmentation of plasminogen activator inhibitor-1 by free fatty acids in breast cancer cells

Yabing Chen, R. Hardy, J. McDonald, 2006 .

Neutrophil-mediated transfer of polar substances from liposomes to mammary tumor cells in vitro

D. Welch, P. Aeed, M. Cho, 1989 .

Subsets of ATP‐sensitive potassium channel (KATP) inhibitors increase gap junctional intercellular communication in metastatic cancer cell lines independent of SUR expression

Kedar S Vaidya, D. Welch, A. Landar, 2012, FEBS letters.

In vitro biophysical, microspectroscopic and cytotoxic evaluation of metastatic and non-metastatic cancer cells in responses to anti-cancer drug.

Elizabeth Vargis, D. Welch, Anhong Zhou, 2015, Analytical methods : advancing methods and applications.

DCLK1 isoforms and aberrant Notch signaling in the regulation of human and murine colitis

S. Anant, Jason R. Stubbs, D. Welch, 2021, Cell death discovery.

Preclinical Drug Development Must Consider the Impact on Metastasis

K. Hunter, L. Matrisian, Yibin Kang, 2009, Clinical Cancer Research.

Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones.

D. Welch, S. A. McClure, P. Aeed, 1994, Anticancer Research.

Cancer metastasis : experimental and clinical strategies : proceedings of a symposium held in Kalamazoo, Michigan, September 15-17, 1985

L. Liotta, D. Welch, B. Bhuyan, 1986 .

The isolated C-terminal nuclear localization sequence of the breast cancer metastasis suppressor 1 is disordered.

D. Pantoja-Uceda, J. Neira, D. Welch, 2019, Archives of biochemistry and biophysics.

Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy

N. Shah, D. Welch, A. Karseladze, 2017, Autophagy.

Mitochondrial polymorphisms contribute to aging phenotypes in MNX mouse models

R. Jensen, D. Welch, A. Brinker, 2018, Cancer and Metastasis Reviews.

Roles of the mitochondrial genetics in cancer metastasis: not to be ignored any longer

D. Welch, C. J. Vivian, T. Beadnell, 2018, Cancer and Metastasis Reviews.

Breast Cancer Metastasis Suppressor-1 Differentially Modulates Growth Factor Signaling*

Kedar S Vaidya, G. Casey, D. Welch, 2008, Journal of Biological Chemistry.

Genetic and epigenetic regulation of human breast cancer progression and metastasis

D. Welch, L. Wei, L. L. Wei, 1998 .

A MSC-ing link in metastasis?

D. Welch, D. Hurst, 2007, Nature Medicine.

The KISS1 metastasis suppressor appears to reverse the Warburg effect by shifting from glycolysis to mitochondrial beta-oxidation

D. Welch, Wen Liu, Sharon J Manley, 2017, Journal of Molecular Medicine.

MCF-7 Cells Expressing Nuclear Associated Lysyl Oxidase-like 2 (LOXL2) Exhibit an Epithelial-to-Mesenchymal Transition (EMT) Phenotype and Are Highly Invasive in Vitro*

D. Welch, D. Moore, Li Xu, 2013, The Journal of Biological Chemistry.

Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells.

Kedar S Vaidya, D. Welch, Jesus Sanchez, 2009, Cancer letters.